You are welcome . I looks like this came out after BetonMace started so it seems to support our trial as very well designed based on our own low Hdl theory. Go Team ! The Jelis Trial seems to be a good predictor of what Amarin later observed and likewise Diamond may be just as good as a predictor of BetonMace results. The cutoff points for low Hdl may have very good implications for us and I am looking  forward to seeing the patient profile / baseline data soon . Thank you again Bear for all you contribute. I hope this Diamond Study data gets some real attention.